Inhibition of ALK, PI3K/MEK and HSP90 in Murine Lung Adenocarcinoma Induced by EML4-ALK Fusion Oncogene
作者： Zhao Chen , Takaaki Sasaki , Xiaohong Tan , Julian Carretero , Takeshi Shimamura
DOI: 10.1158/0008-5472.CAN-10-1671
关键词:
摘要: … (ALK) kinase occur in 3% to 13% of non–small cell lung cancer … for lung cancers driven by an activated EML4-ALK chimeric … In this model, the ALK kinase inhibitor TAE684 produced …
aacrjournals.org
elsevier.com
sci-hub.se 参考文章(49)
Sven Perner, Patrick L Wagner, Francesca Demichelis, Rohit Mehra, Christopher J LaFargue, Benjamin J Moss, Stefanie Arbogast, Alex Soltermann, Walter Weder, Thomas J Giordano, David G Beer, David S Rickman, Arul M Chinnaiyan, Holger Moch, Mark A Rubin, EML4-ALK Fusion Lung Cancer: A Rare Acquired Event Neoplasia. ,vol. 10, pp. 298- 302 ,(2008) , 10.1593/NEO.07878
Ren-Yuan Bai, Tao Ouyang, Cornelius Miething, Stephan W. Morris, Christian Peschel, Justus Duyster, Nucleophosmin–anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway Blood. ,vol. 96, pp. 4319- 4327 ,(2000) , 10.1182/BLOOD.V96.13.4319
Swee Sharp, Paul Workman, Inhibitors of the HSP90 molecular chaperone: current status. Advances in Cancer Research. ,vol. 95, pp. 323- 348 ,(2006) , 10.1016/S0065-230X(06)95009-X
Ruth H. Palmer, Emma Vernersson, Caroline Grabbe, Bengt Hallberg, Anaplastic lymphoma kinase: signalling in development and disease Biochemical Journal. ,vol. 420, pp. 345- 361 ,(2009) , 10.1042/BJ20090387
Andrea D. Basso, David B. Solit, Gabriela Chiosis, Banabihari Giri, Philip Tsichlis, Neal Rosen, Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function. Journal of Biological Chemistry. ,vol. 277, pp. 39858- 39866 ,(2002) , 10.1074/JBC.M206322200
O. M. Grbovic, A. D. Basso, A. Sawai, Q. Ye, P. Friedlander, D. Solit, N. Rosen, V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 57- 62 ,(2006) , 10.1073/PNAS.0609973103
Lucia Regales, Marissa N. Balak, Yixuan Gong, Katerina Politi, Ayana Sawai, Carl Le, Jason A. Koutcher, David B. Solit, Neal Rosen, Maureen F. Zakowski, William Pao, Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors. PLOS ONE. ,vol. 2, ,(2007) , 10.1371/JOURNAL.PONE.0000810
J. A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland, J. O. Park, N. Lindeman, C.-M. Gale, X. Zhao, J. Christensen, T. Kosaka, A. J. Holmes, A. M. Rogers, F. Cappuzzo, T. Mok, C. Lee, B. E. Johnson, L. C. Cantley, P. A. Janne, MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Science. ,vol. 316, pp. 1039- 1043 ,(2007) , 10.1126/SCIENCE.1141478
Mercedes E Gorre, Mansoor Mohammed, Katharine Ellwood, Nicholas Hsu, Ron Paquette, P Nagesh Rao, Charles L Sawyers, Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification Science. ,vol. 293, pp. 876- 880 ,(2001) , 10.1126/SCIENCE.1062538
Scott B. Ficarro, Guillaume Adelmant, Maria N. Tomar, Yi Zhang, Vincent J. Cheng, Jarrod A. Marto, Magnetic Bead Processor for Rapid Evaluation and Optimization of Parameters for Phosphopeptide Enrichment Analytical Chemistry. ,vol. 81, pp. 4566- 4575 ,(2009) , 10.1021/AC9004452